Thalassaemias
57 results
1 - 57Psychological therapies for thalassaemia
Treatment of dental and orthodontic complications in thalassaemia
Splenectomy for people with thalassaemia major or intermedia
Growth hormone therapy for people with thalassaemia
Hydroxyurea (hydroxycarbamide) for transfusion‐dependent β‐thalassaemia
Hematopoietic stem cell transplantation for people with β‐thalassaemia
Zinc supplements for treating thalassaemia and sickle cell disease
Deferasirox for managing iron overload in people with thalassaemia
Treatment for osteoporosis in people with beta‐thalassaemia
Oral deferiprone for iron chelation in people with thalassaemia
Hydroxyurea for reducing blood transfusion in non‐transfusion dependent beta thalassaemias
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay‐Sachs disease
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion‐dependent thalassaemia
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia
Calcium channel blockers for preventing cardiomyopathy due to iron overload in people with transfusion‐dependent beta thalassaemia
Foetal haemoglobin inducers for reducing blood transfusion in non‐transfusion‐dependent beta‐thalassaemias
Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia
Blood transfusions for treating acute chest syndrome in people with sickle cell disease
Blood transfusion for treating malarial anaemia: Cochrane systematic review
Deferasirox for managing transfusional iron overload in people with sickle cell disease
Pain management for sickle cell disease in children and adults: Cochrane systematic review
Hydroxyurea (hydroxycarbamide) for sickle cell disease
Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell transplant (HSCT) recipients with a haematological condition